Phase Ⅰa Clinical Study of Hawthorn Red Pigment Combined With Standard Analgesic for Refractory Cancer Pain

NCT05561023 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

14

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hawthorn Red Combined Refractory Cancer Pain

Interventions

DRUG: Hawthorn red pigment

Sponsor

Fujian Cancer Hospital